Autoimmune rheumatic diseases and COVID-19 vaccination: a retrospective cross-sectional study from Astana.

The vaccination was found to be safe in patients with rheumatic diseases. Fear of autoimmune status was the major reason for vaccine reluctance. All reported adverse events were minor. The minority subgroup within the sample had subsequent breakthrough infections or autoimmune disease flare-ups.